The entity of regional nodal recurrence is not specifically mentioned in the guidelines although it is an emerging clinical situation with the introduction of new molecular imaging techniques like choline and more recently PSMA PET-CT in the restaging of recurrent PCa [2]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.